CERUS CORP ($CERS)
Filing Information
| Accession Number | 0001296322-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 10, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
181,114
Total Value
$250,937.78
P&L
+inf% (+$100,500.40)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Mar 5, 2026 | Grant/Award | 55,220 | $0.00 | $0.00 | 1,004,995 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 5, 2026 | Sale | 61,233 | $2.06 | $126,305.31 | 943,762 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 6, 2026 | Sale | 24,235 | $2.01 | $48,603.29 | 919,527 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 9, 2026 | Sale | 40,426 | $1.88 | $76,029.18 | 879,101 | Direct | โ | View Details |